Technology Transactions and Licensing

We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.

Key Contacts

Meet Our Team

Areas of Focus

Expand All Collapse All

Recognition

  • Award Text

    Among the Best Firms in Massachusetts for Technology

    Chambers USA

    2020-2023

  • Award Text

    Life Cycle Firm of the Year

    LMG Life Sciences

    2012-2023

  • Award Text

    Top Law Firm for Technology Transactions

    The Legal 500

    2010-2023

  • Chambers Global – Recognized 28 WilmerHale lawyers and 28 practice areas, including our Technology and Life Sciences Practices (International & Cross Border), in its 2022 edition.
  • Chambers USA: America’s Leading Lawyers for Business – Named our Technology Practice among the best in Massachusetts in its 2020-2023 editions.
  • The Legal 500 United States – Recognized WilmerHale’s Technology Transactions and Licensing practice among top law firms for our work in the areas of Outsourcing and Technology Transactions in its 2010–2023 editions.
  • Best Lawyers in America – Recognized 118 WilmerHale attorneys for 2022, naming 9 as “Lawyers of the Year.”
  • Law360 – Named WilmerHale a Technology Practice Group of the Year from 2016-2018 and 2022, an award recognizing the firm’s key role in the significant matters that made headlines and changed the legal landscape within the past year.
  • LMG Life Sciences – Named WilmerHale the Life Cycle Firm of the Year in 2023 – for the eleventh consecutive year. Awarded the firm a Finance and Transactional Impact Case of the Year Award in 2017 for counseling Editas Medicine in its licensing and collaboration with Allergan, and a Hatch-Waxman Impact Case of the Year Award in 2018.
  • U.S. News - Best Lawyers® – In the 2010–2023 “Best Law Firms” rankings, our Corporate, Mergers and Acquisitions, and Venture Capital Practices were ranked in the first tier nationally and in Boston, along with our Corporate Practice also being ranked in the first tier in New York and Washington DC. Our Technology Practice was also ranked in the first tier nationally and in Boston.
  • IAM Patent 1000 – Ranked as a leading firm for litigation in the US and UK, and in regional US rankings in California, Colorado, the DC Metro area, Massachusetts and New York (2018–2021).
  • In Vivo – Named Regeneron’s novel deal with Decibel Therapeutics, represented by WilmerHale, as the Top Alliance 2017 Deal of the Year.

Insights & News

  • Client Alert
JUNE 9, 2026

Revised EU Technology Transfer Block Exemption Regulation and Guidelines

Last month, the European Union's revised Technology Transfer Block Exemption Regulation and accompanying Guidelines came into force, replacing the previous 2014 framework.
  • Publication
May 22, 2026

2026 IPO, Venture Capital and M&A Reports

WilmerHale’s 2026 IPO, Venture Capital and M&A Reports provide insight into market conditions across the capital markets landscape, with analysis of key trends shaping offerings, financing activity and global dealmaking.
  • Client Alert
MARCH 5, 2026

Trump Administration Charts Ambitious Path Toward US Critical Mineral Dominance

The Trump Administration is becoming increasingly focused, and ambitious, in implementing its agenda to secure US access to critical minerals and rare earth materials.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.